Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BILI NYSE:CLVT NASDAQ:MEDP NYSE:RTO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBILIBilibili$25.20+2.5%$20.25$12.72▼$31.77$10.28B0.915.94 million shs3.49 million shsCLVTClarivate$4.23-1.9%$4.29$3.04▼$7.15$2.94B1.475.38 million shs5.28 million shsMEDPMedpace$311.87-2.3%$307.47$250.05▼$440.38$9.17B1.47379,535 shs375,011 shsRTORentokil Initial$23.82+2.0%$23.61$19.60▼$34.07$11.80B0.94798,177 shs476,118 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBILIBilibili+2.48%+17.48%+24.44%+55.46%+62.27%CLVTClarivate-2.02%-2.08%-0.59%+25.07%-33.85%MEDPMedpace-2.28%-3.60%+3.03%+5.26%-28.63%RTORentokil Initial+1.99%+3.70%+2.60%+3.11%-21.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBILIBilibili1.6951 of 5 stars1.53.00.00.02.41.71.9CLVTClarivate2.2609 of 5 stars1.91.00.00.02.64.21.9MEDPMedpace4.2832 of 5 stars2.11.00.04.62.34.22.5RTORentokil Initial1.9908 of 5 stars0.03.02.50.02.20.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBILIBilibili 3.00Buy$23.79-5.60% DownsideCLVTClarivate 1.75Reduce$4.8314.26% UpsideMEDPMedpace 2.21Hold$344.8210.56% UpsideRTORentokil Initial 2.80Moderate BuyN/AN/ACurrent Analyst Ratings BreakdownLatest CLVT, RTO, BILI, and MEDP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/18/2025CLVTClarivateJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Hold$5.20 ➝ $4.507/17/2025BILIBilibiliBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$25.00 ➝ $27.007/15/2025BILIBilibiliHSBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy7/8/2025BILIBilibiliSanford C. BernsteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$28.006/24/2025MEDPMedpaceBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform ➝ Equal Weight$300.005/21/2025BILIBilibiliHsbc Global ResSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/21/2025BILIBilibiliHSBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$21.50 ➝ $22.505/15/2025RTORentokil InitialSanford C. BernsteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeMarket Perform ➝ Underperform4/23/2025MEDPMedpaceTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$333.00 ➝ $300.004/23/2025MEDPMedpaceRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$340.00 ➝ $313.004/22/2025MEDPMedpaceWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform(Data available from 7/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBILIBilibili$28.17B0.37$0.46 per share54.42$4.64 per share5.43CLVTClarivate$2.56B1.13$1.65 per share2.57$7.23 per share0.59MEDPMedpace$2.16B4.16$13.63 per share22.88$26.56 per share11.74RTORentokil Initial$6.95B1.73$2.63 per share9.07$10.70 per share2.23Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBILIBilibili-$184.51M-$0.20N/A56.00N/A-2.15%-2.59%-1.12%8/28/2025 (Estimated)CLVTClarivate-$636.70M-$0.97N/A6.22N/A-26.32%8.75%3.96%7/30/2025 (Estimated)MEDPMedpace$404.39M$13.1023.8122.835.7719.31%54.36%20.81%7/21/2025 (Confirmed)RTORentokil Initial$392.32M$1.5115.7716.89N/AN/AN/AN/A7/31/2025 (Estimated)Latest CLVT, RTO, BILI, and MEDP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025CLVTClarivate$0.18N/AN/AN/A$587.17 millionN/A7/21/2025Q2 2025MEDPMedpace$3.01N/AN/AN/A$537.70 millionN/A4/29/2025Q1 2025CLVTClarivate$0.12$0.14+$0.02-$0.15$574.03 million$593.70 million4/21/2025Q1 2025MEDPMedpace$3.06$3.67+$0.61$3.67$528.38 million$558.57 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBILIBilibiliN/AN/AN/AN/AN/ACLVTClarivateN/AN/AN/AN/AN/AMEDPMedpaceN/AN/AN/AN/AN/ARTORentokil Initial$0.692.90%N/A45.70%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBILIBilibili0.231.361.36CLVTClarivate0.900.880.88MEDPMedpaceN/A0.730.73RTORentokil Initial0.590.810.72Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBILIBilibili16.08%CLVTClarivate85.72%MEDPMedpace77.98%RTORentokil Initial9.91%Insider OwnershipCompanyInsider OwnershipBILIBilibili22.20%CLVTClarivate23.18%MEDPMedpace20.30%RTORentokil InitialN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBILIBilibili8,088417.99 million325.19 millionOptionableCLVTClarivate12,000683.09 million524.75 millionOptionableMEDPMedpace5,90028.74 million22.91 millionOptionableRTORentokil Initial68,485505.21 millionN/ANot OptionableCLVT, RTO, BILI, and MEDP HeadlinesRecent News About These CompaniesEnvestnet Asset Management Inc. Has $17.82 Million Stock Position in Rentokil Initial PLC (NYSE:RTO)July 18 at 3:28 AM | marketbeat.comTick Season Alert: Terminix Identifies 25 High-Risk States for Increased Tick ActivityJuly 15, 2025 | prnewswire.comRentokil Initial PLC (NYSE:RTO) Stock Holdings Increased by Iridian Asset Management LLC CTJuly 9, 2025 | marketbeat.comRentokil Initial PLC (NYSE:RTO) Position Lowered by Brown Advisory Inc.July 9, 2025 | marketbeat.comVontobel Holding Ltd. Invests $279,000 in Rentokil Initial PLC (NYSE:RTO)July 9, 2025 | marketbeat.comRentokil Initial (NYSE:RTO) Shares Gap Down - Here's What HappenedJuly 8, 2025 | marketbeat.comSumitomo Mitsui Trust Group Inc. Sells 19,833 Shares of Rentokil Initial PLC (NYSE:RTO)July 6, 2025 | marketbeat.comRTO Stock Price Quote | MorningstarJuly 3, 2025 | morningstar.comMWhy UK equities dominate my Stocks and Shares ISAJuly 2, 2025 | msn.comRentokil Initial Announces Total Voting Rights UpdateJuly 2, 2025 | theglobeandmail.comRentokil Initial PLC ADR Company & People | RTO | Barron'sJune 29, 2025 | barrons.comRentokil Initial PLC ADR Advanced Charts | RTO | Barron'sJune 29, 2025 | barrons.comRentokil Initial PLC ADR Research & Ratings | RTO | Barron'sJune 27, 2025 | barrons.comHicks Capital Management LLC Invests $644,000 in Rentokil Initial PLC (NYSE:RTO)June 27, 2025 | marketbeat.comThe Bed Bug Boom: Terminix Reveals Top 50 Infested U.S. CitiesJune 9, 2025 | gurufocus.comThe Bed Bug Boom: Terminix Reveals Top 50 Infested U.S. CitiesJune 9, 2025 | finance.yahoo.comRentokil Initial rallies Monday, outperforms marketJune 2, 2025 | marketwatch.comRentokil rises after selling off French workwear businessMay 28, 2025 | proactiveinvestors.co.ukRentokil Initial to Sell Workwear Business in France to H.I.G. Capital for $464 MillionMay 28, 2025 | wsj.comRentokil Initial CEO Increases Stake through Dividend ReinvestmentMay 19, 2025 | tipranks.comRentokil stock rating downgraded at Bernstein SocGenMay 16, 2025 | investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesJoby vs. Archer: Which eVTOL Stock Is Better for Your Portfolio?By Jeffrey Neal Johnson | July 14, 2025View Joby vs. Archer: Which eVTOL Stock Is Better for Your Portfolio?Rigetti Computing: Cantor's Bullish Call May Be Just the StartBy Jeffrey Neal Johnson | July 3, 2025View Rigetti Computing: Cantor's Bullish Call May Be Just the StartThe Boring Is Beautiful Portfolio: 3 Stocks for a Worried WorldBy Jeffrey Neal Johnson | June 22, 2025View The Boring Is Beautiful Portfolio: 3 Stocks for a Worried WorldCrowdStrike vs. Cloudflare: Which Cybersecurity Stock Wins?By Chris Markoch | July 11, 2025View CrowdStrike vs. Cloudflare: Which Cybersecurity Stock Wins?3 Utility Stocks That Combine Income and StabilityBy Chris Markoch | July 2, 2025View 3 Utility Stocks That Combine Income and StabilityCLVT, RTO, BILI, and MEDP Company DescriptionsBilibili NASDAQ:BILI$25.20 +0.61 (+2.48%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$25.22 +0.02 (+0.06%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bilibili Inc. provides online entertainment services for the young generations in the People's Republic of China. It offers a range of digital content, including professional user generated videos, mobile games, and value-added services, such as live broadcasting, occupationally generated videos, audio drama on Maoer, and comics on Bilibili Comic. The company also provides advertising services; and IP derivatives and other services. In addition, it engages in the business and technology development activities; e-commerce business; and video, comics, and game distribution activities. Bilibili Inc. was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.Clarivate NYSE:CLVT$4.23 -0.08 (-1.86%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$4.14 -0.09 (-2.10%) As of 07/18/2025 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.Medpace NASDAQ:MEDP$311.87 -7.29 (-2.28%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$311.83 -0.04 (-0.01%) As of 07/18/2025 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.Rentokil Initial NYSE:RTO$23.82 +0.47 (+2.01%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$23.84 +0.02 (+0.06%) As of 07/18/2025 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers. The company provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats. In addition, it engages in the supply and maintenance of workwear and protective equipment. Further, the company offers property care services; and provides a range of specialist cleaning services, such as graffiti removal deep cleaning of kitchens and washrooms, trauma cleaning, and flood or fire damage cleaning, as well as specialist medical and hygiene services. Rentokil Initial plc was founded in 1903 and is headquartered in Crawley, the United Kingdom. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
